HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bimodal role of NADPH oxidases in the regulation of biglycan-triggered IL-1β synthesis.

Abstract
Biglycan, a ubiquitous proteoglycan, acts as a danger signal when released from the extracellular matrix. As such, biglycan triggers the synthesis and maturation of interleukin-1β (IL-1β) in a Toll-like receptor (TLR) 2-, TLR4-, and reactive oxygen species (ROS)-dependent manner. Here, we discovered that biglycan autonomously regulates the balance in IL-1β production in vitro and in vivo by modulating expression, activity and stability of NADPH oxidase (NOX) 1, 2 and 4 enzymes via different TLR pathways. In primary murine macrophages, biglycan triggered NOX1/4-mediated ROS generation, thereby enhancing IL-1β expression. Surprisingly, biglycan inhibited IL-1β due to enhancement of NOX2 synthesis and activation, by selectively interacting with TLR4. Synthesis of NOX2 was mediated by adaptor molecule Toll/IL-1R domain-containing adaptor inducing IFN-β (TRIF). Via myeloid differentiation primary response protein (MyD88) as well as Rac1 activation and Erk phosphorylation, biglycan triggered translocation of the cytosolic NOX2 subunit p47(phox) to the plasma membrane, an obligatory step for NOX2 activation. In contrast, by engaging TLR2, soluble biglycan stimulated the expression of heat shock protein (HSP) 70, which bound to NOX2, and consequently impaired the inhibitory function of NOX2 on IL-1β expression. Notably, a genetic background lacking biglycan reduced HSP70 expression, rescued the enhanced renal IL-1β production and improved kidney function of Nox2(-/y) mice in a model of renal ischemia reperfusion injury. Here, we provide a novel mechanism where the danger molecule biglycan influences NOX2 synthesis and activation via different TLR pathways, thereby regulating inflammation severity. Thus, selective inhibition of biglycan-TLR2 or biglycan-TLR4 signaling could be a novel therapeutic approach in ROS-mediated inflammatory diseases.
AuthorsLouise Tzung-Harn Hsieh, Helena Frey, Madalina-Viviana Nastase, Claudia Tredup, Adrian Hoffmann, Chiara Poluzzi, Jinyang Zeng-Brouwers, Tina Manon-Jensen, Katrin Schröder, Ralf P Brandes, Renato V Iozzo, Liliana Schaefer
JournalMatrix biology : journal of the International Society for Matrix Biology (Matrix Biol) Vol. 49 Pg. 61-81 (Jan 2016) ISSN: 1569-1802 [Electronic] Netherlands
PMID26689330 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.
Chemical References
  • BGN protein, human
  • Biglycan
  • Interleukin-8
  • Membrane Glycoproteins
  • Toll-Like Receptors
  • NADH, NADPH Oxidoreductases
  • Cybb protein, mouse
  • NADPH Oxidase 1
  • NADPH Oxidase 2
  • NADPH Oxidase 4
  • NADPH Oxidases
  • NOX1 protein, mouse
  • Nox4 protein, mouse
Topics
  • Animals
  • Biglycan (metabolism)
  • Cells, Cultured
  • Interleukin-8 (metabolism)
  • Kidney (injuries, metabolism)
  • Macrophages (metabolism)
  • Membrane Glycoproteins (metabolism)
  • Mice
  • NADH, NADPH Oxidoreductases (metabolism)
  • NADPH Oxidase 1
  • NADPH Oxidase 2
  • NADPH Oxidase 4
  • NADPH Oxidases (metabolism)
  • Reperfusion Injury (etiology)
  • Signal Transduction
  • Toll-Like Receptors (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: